Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Risk of miscarriage in women conceiving after medically assisted reproduction with an ultrasound-verified viable pregnancy at 6-8 weeks' gestation

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Co-treatment with letrozole during ovarian stimulation for IVF/ICSI: a systematic review and meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  2. Reintroducing serum FSH measurement during ovarian stimulation for ART

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Meditation and mindfulness reduce perceived stress in women with recurrent pregnancy loss: a randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Clusters of smooth endoplasmic reticulum are absent in oocytes from unstimulated women

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Stress and depression among women and men who have experienced recurrent pregnancy loss: focusing on both sexes

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Co-treatment with letrozole during ovarian stimulation for IVF/ICSI: a systematic review and meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  2. School performance in Danish children exposed to maternal type 1 diabetes in utero: A nationwide retrospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cardiovascular function in 8- to 9-year-old singletons born after ART with frozen and fresh embryo transfer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

RESEARCH QUESTION: What is the risk of miscarriage after a viable fetus verified on ultrasound at 6-8 weeks' gestation among women who conceive with medically assisted reproduction (MAR), stratified by type of fertility treatment?

DESIGN: A nationwide register-based cohort study of women identified in the Danish ART-Registry with a viable singleton pregnancy at 6-8 weeks' gestation between 2007 and 2010 (n = 10,011). Women were identified from The Danish Fetal Medicine Database (DFMD), which holds information on early (between 6-8 and 11-14 weeks) and late (between 11-14 and 22 weeks) miscarriages. The late miscarriage rate was compared with a control group of naturally conceived pregnancies with a viable fetus at 11-14 weeks' gestation from 2008 to 2010, identified in the DFMD (n = 146,932).

RESULTS: In the MAR1 cohort, the overall miscarriage rate was 11.8% (1091/9261) after an ultrasound verified viable pregnancy at 6-8 weeks' gestation. Most miscarriages occurred before the 11-14-week scan (1035/1091 [94.9%]). The early miscarriage rate was slightly higher in women who conceived with frozen embryo transfer compared with intrauterine insemination (IUI), corresponding to an adjusted OR of 1.31 (1.02 to 1.68). We found no significant risk associated with IVF and intracytoplasmic sperm injection compared with IUI pregnancies. The late miscarriage rate was 0.8% in women conceiving with MAR and 0.6% among controls (P = 0.013).

CONCLUSIONS: After adjustment for maternal characteristics, none of the fertility treatment types were associated with an increased risk of miscarriage compared with naturally conceiving women.

Original languageEnglish
JournalReproductive BioMedicine Online
Volume39
Issue number5
Pages (from-to)819-826
Number of pages8
ISSN1472-6483
DOIs
Publication statusPublished - Nov 2019

ID: 58967898